Alison Armour
Corporate Officer/Principal at Royal College of Physicians & Surgeons of Glasgow
Profile
Presently, Alison A. Armour holds the position of Senior Vice President-Research & Development at Halozyme Therapeutics, Inc. Dr. Armour is also Member of Royal College of Physicians & Surgeons of Glasgow. Dr. Armour previously occupied the position of Vice President-Oncology at GlaxoSmithKline Plc, Vice President-Oncology at Novartis AG and Chief Medical Officer of Endocyte, Inc. (a subsidiary of Novartis AG) and Director-Global Medical Science at AstraZeneca Plc. Alison A. Armour received an undergraduate degree, a graduate degree and a doctorate from the University of Glasgow.
Alison Armour active positions
Companies | Position | Start |
---|---|---|
Royal College of Physicians & Surgeons of Glasgow
Royal College of Physicians & Surgeons of Glasgow Other Consumer ServicesConsumer Services The Royal College of Physicians and Surgeons of Glasgow is a multidisciplinary organization that sets standards of care for the prevention and treatment of sickness and trauma in travelers. The British company has published a good practice guide for providing a travel health service, which defines the standards of care every practitioner should achieve in their practice of travel medicine for the health and safety of the international traveler. The organization offers a wide range of membership benefits and discounts on clinical and non-clinical skills courses, conferences, and e-learning. The private company also provides examinations and assessments across medical, surgical, and dental specialties to advance the profession and improve patient care through continuing professional development. | Corporate Officer/Principal | - |
Former positions of Alison Armour
Companies | Position | End |
---|---|---|
HALOZYME THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2019-12-31 |
NOVARTIS AG | Corporate Officer/Principal | 2015-06-30 |
GSK PLC | Corporate Officer/Principal | 2015-06-30 |
ASTRAZENECA PLC | Corporate Officer/Principal | 2011-07-31 |
ENDOCYTE, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Alison Armour
University of Glasgow | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
ASTRAZENECA PLC | Health Technology |
HALOZYME THERAPEUTICS, INC. | Health Technology |
NOVARTIS AG | Health Technology |
GSK PLC | Health Technology |
Private companies | 2 |
---|---|
Endocyte, Inc.
Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
Royal College of Physicians & Surgeons of Glasgow
Royal College of Physicians & Surgeons of Glasgow Other Consumer ServicesConsumer Services The Royal College of Physicians and Surgeons of Glasgow is a multidisciplinary organization that sets standards of care for the prevention and treatment of sickness and trauma in travelers. The British company has published a good practice guide for providing a travel health service, which defines the standards of care every practitioner should achieve in their practice of travel medicine for the health and safety of the international traveler. The organization offers a wide range of membership benefits and discounts on clinical and non-clinical skills courses, conferences, and e-learning. The private company also provides examinations and assessments across medical, surgical, and dental specialties to advance the profession and improve patient care through continuing professional development. | Consumer Services |
- Stock Market
- Insiders
- Alison Armour